Stroke AHA/ASA/X
Jun 12, 2025, 06:59
DOACs vs. Warfarin in Cerebral Venous Thrombosis: ACTION-CVT Study Shows Safer Profile Without Compromising Efficacy
Stroke AHA/ASA shared on X:
“STROKE In the Multicenter International Study ACTION CVT, patients with Cerebral Venous Thrombosis treated with DOACs had similar rate of thrombosis recurrence and recanalization rates, but lower risk of major hemorrhages, when compared to warfarin (1/3)”
Title: Low incidence of thromboembolism with Fiix-monitored warfarin compared to conventional warfarin and DOACs in patients with AF.
Authors: Arnar B. Ingason, Brynja R. Gudmundsdottir, Ragnar Palsson, Johann P. Hreinsson, Sigrun H. Lund, Loic R. Letertre, Edward Rumba, Arnar S. Agustsson, Einar S. Bjornsson, Pall T. Onundarson.
Read more about it in Blood Vessels, Thrombosis & Hemostasis (2025).
Discover more in Hemostasis Today.
Arnar B. Ingason
Arnar S. Agustsson
ASH
Blood Vessels
Brynja R. Gudmundsdottir
BVTH 2025
Cerebral Venous Thrombosis
DOACs
DOACs vs. Warfarin
Edward Rumba
Einar S. Bjornsson
Johann P. Hreinsson
Loic R. Letertre
Pall T. Onundarson.
Ragnar Palsson
Sigrun H. Lund
Study ACTION CVT
Thrombosis & Hemostasis
Thrombosis and Haemostasis
-
Sep 18, 2025, 06:50Fetal Hereditary TTP Featured in NEJM – Senior Author Nishant Rajendra Tiwari
-
Sep 17, 2025, 10:54Mitapivat Boosts ATP in Red Cells: Dr. William Aird on New Hope for Hemolytic Disorder
-
Sep 17, 2025, 08:16Superficial Vein Thrombosis Management: John Fanikos Shares Latest Review
-
Sep 17, 2025, 07:00Maha Othman - ''BIC 2025 is Without a Doubt a Remarkable Scientific Event — and I’m Excited for What Lies Ahead!''
-
Sep 16, 2025, 11:17Glenn Pierce: WHO Issues a Biannual Essential Medicines List
-
Sep 18, 2025, 07:00Rishabh Singh on NEJM Letter: FVIII Aurora Mutation Shows Increased Activity and Reduced APC Response
-
Sep 18, 2025, 02:25Flora Peyvandi Highlights 'Inflammatory Memory of Stem Cells' – New Insights for Hematologic Diseases
-
Sep 17, 2025, 16:32Endovascular Today: Dr. Eric Secemsky Analyzes Impact of Paclitaxel Pause on Peripheral Artery Disease Care
-
Sep 17, 2025, 16:28Haemnet Showcases Research on Severe Haemophilia A Patients Adapting to Emicizumab Therapy
-
Sep 17, 2025, 16:19Todd Villines: Coronary Artery Disease - A BIG Movement to Change
-
Sep 16, 2025, 14:59A New Era in Antiplatelet Therapy for CABG?
-
Sep 16, 2025, 07:44Artificial Blood Breakthrough in Japan: Long Shelf Life, No Type Matching, and a Purple Future
-
Sep 16, 2025, 02:44Wolfgang Miesbach Highlights First Inhibitor Case After Hemophilia A Gene Therapy (Giroctocogene Fitelparvovec)
-
Sep 12, 2025, 15:21Christian Schäfer: INR Self-Management Has Officially Been Given Class IA Status in the ESC Guidelines
-
Sep 9, 2025, 20:15Linking a Single Dominant Antibody to HIT: A Novel Study Led by Ishac Nazy, Donald Arnold, and John G. Kelton
-
Sep 18, 2025, 06:34'A New Era in Mechanical Thrombectomy?' – Sripal Bangalore Highlights SYMPHONY-PE IDE Study
-
Sep 17, 2025, 10:49Living with Glanzmann Thrombasthenia․ Eliza VanZweden’s Story of Resilience and Advocacy
-
Sep 17, 2025, 10:22Abdul Mannan: Turning Medical Podcasts into Active Learning with Structured Tools
-
Sep 17, 2025, 09:43Global Blood Supply Under Threat: David McIntosh Calls for Action to Support Transfusion Services
-
Sep 17, 2025, 09:08Coronary Arteries, Pericardial Cavity, and the Hidden Danger of Cardiac Tamponade During PCI-By Ahmed Ata
Sep 18, 2025, 06:50
Sep 17, 2025, 16:19
Sep 17, 2025, 10:36